How should I manage a patient with elevated intact parathyroid hormone (109 pg/mL) despite normal serum calcium (9.0 mg/dL) and adequate 25‑hydroxyvitamin D (31 ng/mL)?

Management of Elevated PTH (109 pg/mL) with Normal Calcium and Adequate Vitamin D

This patient has normocalcemic hyperparathyroidism that requires systematic evaluation to exclude secondary causes before considering primary hyperparathyroidism, with calcium supplementation being the first-line intervention if dietary calcium intake is insufficient.

Initial Diagnostic Approach

Confirm True Normocalcemia

• Measure ionized calcium to confirm normocalcemia, as total calcium can be misleading in borderline cases 1
• Ensure calcium measurements are consistently normal over time, not just a single value 2

Exclude Secondary Hyperparathyroidism

Assess dietary calcium intake first - this is the most commonly overlooked reversible cause 3:

• Obtain detailed dietary history focusing on daily calcium consumption
• If calcium intake is inadequate (typically <1000-1200 mg/day), this alone can drive PTH elevation even with normal serum calcium and vitamin D 3, 4
• Trial of calcium supplementation 600 mg twice daily for 2-3 weeks can both diagnose and treat calcium-deficiency-induced secondary hyperparathyroidism 3
• Recheck PTH after supplementation; normalization confirms the diagnosis 3

Verify vitamin D adequacy 5:

• While 25-hydroxyvitamin D of 31 ng/mL is technically "adequate," levels below 30 ng/mL are associated with secondary hyperparathyroidism 5
• Consider maintaining levels >30 ng/mL (some guidelines suggest >50 ng/mL) for optimal PTH suppression 5
• The relationship between vitamin D and PTH is modified by calcium intake - inadequate calcium blunts vitamin D's PTH-suppressing effect 4

Assess renal function 5:

• Calculate eGFR to exclude chronic kidney disease as a cause
• Even mild CKD (Stage 3, eGFR 30-60 mL/min/1.73 m²) commonly causes secondary hyperparathyroidism 5
• If eGFR <60 mL/min/1.73 m², this likely explains the elevated PTH 5

Check 24-hour urine calcium 1, 6:

• Low urinary calcium excretion suggests calcium deprivation (inadequate intake or absorption) 7
• This supports secondary rather than primary hyperparathyroidism

Screen for malabsorption 6:

• History of gastrointestinal disorders, bariatric surgery, or chronic diarrhea
• These conditions impair calcium absorption and drive secondary hyperparathyroidism 6

Management Algorithm

If Secondary Causes Identified:

For inadequate calcium intake 3:

• Start calcium carbonate 600 mg (elemental calcium) twice daily with meals
• Recheck PTH in 2-4 weeks
• Expected outcome: PTH normalizes to <65 pg/mL while maintaining normocalcemia 3

For persistent vitamin D insufficiency 5:

• Supplement with ergocalciferol or cholecalciferol to achieve 25-hydroxyvitamin D >30 ng/mL (ideally >50 ng/mL)
• Reassess after 3-6 months of adequate vitamin D status 1

For CKD Stage 3-4 5:

• Target PTH ranges differ by CKD stage (not the normal range used for primary hyperparathyroidism)
• PTH of 109 pg/mL may be appropriate for CKD Stage 3 5
• Consider active vitamin D sterols (calcitriol) only if PTH >300 pg/mL in CKD Stage 3-4 5

If No Secondary Causes Found:

Consider normocalcemic primary hyperparathyroidism 2, 6:

• This diagnosis requires at least 6 months of documented normocalcemia with persistently elevated PTH after excluding all secondary causes 1
• Vitamin D status must be maintained at adequate levels throughout this observation period 1

Perform oral calcium loading test (if available) 1:

• Helps differentiate normocalcemic primary hyperparathyroidism from secondary hyperparathyroidism
• In primary hyperparathyroidism: hypercalcemia develops after loading with failure to suppress PTH 1
• In secondary hyperparathyroidism: PTH appropriately suppresses with calcium loading 1

Assess for target organ involvement 1:

• Bone densitometry (DEXA scan) to evaluate for osteoporosis (T-score <-2.5)
• Renal imaging (ultrasound or CT) for nephrolithiasis or nephrocalcinosis
• 24-hour urine calcium (>250 mg/day in women or >300 mg/day in men suggests primary hyperparathyroidism) 8

Common Pitfalls to Avoid

• Do not diagnose primary hyperparathyroidism prematurely - most cases of normocalcemic hyperparathyroidism are secondary 2, 6
• Do not overlook dietary calcium assessment - this simple intervention resolves many cases 3
• Do not accept a single "adequate" vitamin D level - maintain optimal levels (>30 ng/mL) for at least 6 months before diagnosing primary disease 1
• Do not use active vitamin D (calcitriol) empirically - reserve for specific indications like CKD with PTH >300 pg/mL 5
• Do not order parathyroid imaging unless surgery is being considered for confirmed primary hyperparathyroidism 8

Monitoring

• Recheck calcium, PTH, and vitamin D every 3 months during evaluation 5, 9
• Once stable on calcium supplementation, monitor calcium and PTH every 6 months 9
• Annual assessment of bone health and renal function 9